CSF1R and Parkinson disease: In a model of PD, by murine exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), ablating microglia through inhibition of colony-stimulating factor 1 receptors (CSF1R) exacerbated parkinsonian symptoms and neuropathology.